Oligodendrogliomas Active Not Recruiting Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Oligodendroglioma / [M]Oligodendroglioma NOS / Oligodendroglioma, Well-Differentiated

IndicationStatusPhase
DBCOND0032978 (Oligodendrogliomas)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01609790Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain TumorsTreatment